Cardionomic: HF neurmod developer Cardionomic nets $20m in Series A

Cardionomic said today it raised $20 million in Series A round of financing to support its catheter-based neurmodulation therapy for treating acute decompensated heart failure. Funding is slated to support continued development of the company's device which is designed to treat acute decompensated heart failure, a condition in which fluid accumulates in the lungs and other [...]The post HF neurmod developer Cardionomic nets $20m in Series A appeared first on MassDevice.